Idexx Laboratories (IDXX) Deferred Taxes (2009 - 2026)

Idexx Laboratories has reported Deferred Taxes for 18 years, with the latest figure at $6.5 million in Q2 2026.

• On a quarterly basis, Deferred Taxes rose 163.74% year-over-year to $6.5 million in Q2 2026; TTM through Jun 2026 was $145.2 million, a 3313.38% increase from a year earlier, with the FY2025 full-year figure at $131.2 million, up 642.3% from the prior year.
• Deferred Taxes was $6.5 million for Q2 2026 at Idexx Laboratories, down from $13.9 million in the prior quarter.
• The five-year high for Deferred Taxes was $93.2 million in Q3 2025, with the low at -$33.6 million in Q4 2023.
• Average Deferred Taxes over 5 years is $2.4 million, with a median of -$2.2 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Deferred Taxes slumped 9186.81% in 2022, then soared 1461.48% in 2025.
• Over 5 years, Deferred Taxes stood at $1.8 million in 2022, then sank by 1938.74% to -$33.6 million in 2023, then soared by 113.93% to $4.7 million in 2024, then soared by 574.27% to $31.5 million in 2025, then plunged by 79.26% to $6.5 million in 2026.
• The last three Deferred Taxes figures came in at $6.5 million (Q2 2026), $13.9 million (Q1 2026), and $31.5 million (Q4 2025), per Business Quant data.